BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8114846)

  • 1. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
    Lotke PA; Ecker ML
    N Engl J Med; 1994 Mar; 330(12):863. PubMed ID: 8114846
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
    Hirsh J
    N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of low-dose heparin--warfarin anticoagulation prophylaxis after total hip replacement arthroplasty.
    Goss TP; Stinchfield FE; Cosgriff SW
    Clin Orthop Relat Res; 1979 Jun; (141):134-7. PubMed ID: 477094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of thrombosis during pregnancy.
    Vilela VS; de Jesús NR; Levy RA
    Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
    [No Abstract]   [Full Text] [Related]  

  • 8. Venous thrombosis: prevention, treatment, and relationship to paradoxical embolization.
    Goldhaber SZ
    Cardiol Clin; 1994 Aug; 12(3):505-16. PubMed ID: 7805083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery].
    Schwarz B; Mittelmeier H
    Aktuelle Traumatol; 1988 Oct; 18(5):226-32. PubMed ID: 2907248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
    Turpie AG
    Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
    [No Abstract]   [Full Text] [Related]  

  • 11. [What is assured in drug prevention of thrombosis with special reference to low molecular weight heparin?].
    Daiss W; Dölle W
    Internist (Berl); 1989 Dec; 30(12):784-9. PubMed ID: 2559898
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery.
    Menzin J; Colditz GA; Regan MM; Richner RE; Oster G
    Arch Intern Med; 1995 Apr; 155(7):757-64. PubMed ID: 7695464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of thrombosis with low molecular weight heparin as the only substance and/or with DHE: results of clinical studies].
    Koppenhagen K; Tröster E; Matthes M; Häring R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1163-6. PubMed ID: 1983504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis against venous thromboembolism after major trauma.
    Osler T; Rogers F
    N Engl J Med; 1997 Feb; 336(8):586; author reply 586-7. PubMed ID: 9036312
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
    Bergqvist D
    Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
    Agnelli G
    Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).
    Samama MM
    Adv Exp Med Biol; 1992; 313():275-81. PubMed ID: 1332441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.